(Q37807129)

English

Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate

scientific article published on November 2, 2010

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

title

Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

1

Illana Gozes

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21050875

retrieved

20 August 2024

language of work or name

1 reference

2 November 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Peptides

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

volume

32

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

page(s)

428-431

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

cites work

Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory

1 reference

stated in

COCI

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1001/ARCHPSYC.62.11.1205

retrieved

30 October 2021

Identifiers

DOI

10.1016/J.PEPTIDES.2010.10.030

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

PubMed publication ID

21050875

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21050875

retrieved

23 August 2017

(Q37807129)

Microtubules, schizophrenia and cognitive behavior: preclinical development of davunetide (NAP) as a peptide-drug candidate

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)